ICU MEDICAL, INC.

ICUI US44930G1076

🆔
Registration No.
2284646
💰
Capitalization
Mid-cap

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

🏢
Founded
1992
Annual Performance 1
2021 2022 2023 2024 2025
12% -33% -38% 53% 1%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
76
🙍
Insiders
10
Person Price Shares Total Published Completed
Greenberg David C.
126.14
USD
602
Bought
75,938
USD
27/08/2025 27/08/2025
Greenberg David C.
126.69
USD
598
Bought
75,760
USD
27/08/2025 27/08/2025
Jain Vivek
CEO
112.12
USD
2,378
Bought
266,613
USD
14/08/2025 14/08/2025
Jain Vivek
CEO
112.92
USD
19,551
Bought
2,207,761
USD
14/08/2025 14/08/2025
Sanzone Virginia Ruth
VP
133.62
USD
700
Sold
93,537
USD
30/05/2025 30/05/2025
Sanzone Virginia Ruth
VP
133.62
USD
700
Sold
93,537
USD
30/05/2025 30/05/2025
Voigtlander Christian B.
COO
128.50
USD
4,985
Sold
640,576
USD
27/05/2025 28/05/2025
Voigtlander Christian B.
COO
128.50
USD
4,985
Sold
640,576
USD
27/05/2025 28/05/2025
Voigtlander Christian B.
COO
131.00
USD
4,945
Sold
647,795
USD
27/05/2025 27/05/2025
Voigtlander Christian B.
COO
131.00
USD
4,945
Sold
647,795
USD
27/05/2025 27/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include ICU MEDICAL, INC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-11% 29% 63% -12% -17% -6% 52%
Last 52W Low 52W High All-Time Low All-Time High β
118.10 108.10 151.04 108.10 151.04
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Smiths Group International Holdings Ltd 1 88,042,250.00 88,042,250.00 29/02/2024 29/02/2024
Smiths Group Plc 1 88,042,250.00 88,042,250.00 29/02/2024 29/02/2024
Voigtlander Christian B. 30 19,129,881.80 637,662.73 04/03/2024 28/05/2025
Jain Vivek 18 12,680,519.76 704,473.32 16/08/2024 14/08/2025
Lopez George A 6 5,550,360.52 925,060.09 04/03/2024 14/03/2024
Woolson Daniel 4 988,457.69 247,114.42 01/12/2023 06/12/2024
Greenberg David C. 5 863,366.26 172,673.25 27/11/2024 27/08/2025
Sanzone Virginia Ruth 4 827,588.33 206,897.08 08/03/2024 30/05/2025
Sousa Ben 3 760,518.40 253,506.13 10/05/2024 15/05/2025
Finney Elisha W 4 281,541.87 70,385.47 16/05/2024 19/05/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.